BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/24/2019 4:48:02 AM | Browse: 190 | Download: 322
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Basic Study |
Article Title |
CARMA3/NF-κB signaling contributes to the tumorigenesis of hepatocellular carcinoma and is inhibited by Sodium Aescinate
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Hui Hou, Wei-Xiang Li, Xiao Cui, Da-Chen zhou, Bin Zhang and Xiao-Ping Geng |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Nature Science Foundation of High Education Institution of Anhui Province |
KJ2017A825 |
Natural Science Foundation of Anhui Province |
1808085MH270 |
Foundation of the Higher Education Institution of Henan Province |
16A320007 |
“Huohua Jihua” Foundation of the Second Hospital of Anhui Medical University Science |
No.2015hhjh05 |
Anhui Medical University Science Foundation |
2017xkj033 |
|
Corresponding Author |
Xiao-Ping Geng, MD, Director, Professor, Department of Hepato-Pancreato-Biliary Surgery, Department of Surgery,, The First Affiliated Hospital of Anhui Medical University, No. 120 Wanshui Road, Gaoxin District, Hefei 230032, Anhui Province, China. xp_geng@163.net |
Key Words |
CARMA3; Nuclear factor kappa-B; Sodium Aescinate; Hepatocellular carcinoma; Tumorigenesis; Liver cancer |
Core Tip |
Hepatocellular carcinoma (HCC) ranked the sixth in the most common malignant tumors and is the most frequent primary liver cancer; nuclear factor kappa-B (NF-κB) signal pathway is commonly activated and exerts critical roles in the progression of HCC. Here, we hypothesized CARMA3 might play an oncogenic role in HCC by activating NF-κB, and explored the relationships between CARMA3 expression and clinicopathological characters. Furthermore, we found Sodium Aescinate, exerted anti-tumor effects possibly by inactivating CARMA3/NF-κB signaling. |
Citation |
Hou H, Li WX, Cui X, Zhou DC, Zhang B, Geng XP. CARMA3/NF-κB signaling contributes to the tumorigenesis of hepatocellular carcinoma and is inhibited by Sodium Aescinate. World J Gastroenterol 2019; 25(36): 5483-5493 |
|
Received |
|
2019-06-17 00:21 |
|
Peer-Review Started |
|
2019-06-18 02:25 |
|
To Make the First Decision |
|
2019-08-05 02:27 |
|
Return for Revision |
|
2019-08-07 00:25 |
|
Revised |
|
2019-08-13 14:42 |
|
Second Decision |
|
2019-08-23 10:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-08-24 04:48 |
|
Articles in Press |
|
2019-08-24 04:48 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-09-09 22:26 |
|
Typeset the Manuscript |
|
2019-09-27 07:26 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345